Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 24, 2010 David Meier	Could Qualcomm Be a Multibagger? Strong returns on equity can generate powerful returns for shareholders.
The Motley Fool August 25, 2010 David Meier	Can MedcoHealth Solutions Produce Big Returns? MedcoHealth Solutions generates incredible returns on equity. Let's see how it does it.
The Motley Fool August 24, 2010 David Meier	Could Alcon Be a Multibagger? Strong returns on equity can generate powerful shareholder returns.
The Motley Fool August 24, 2010 David Meier	Can McKesson Produce Big Returns? McKesson uses its production advantage -- high asset turnover and reasonable leverage -- to generate very attractive returns on equity for shareholders.
The Motley Fool August 24, 2010 David Meier	Can TJX Produce Big Returns? TJX uses its production advantage -- low margins, high asset turnover, and reasonable leverage -- to generate very attractive returns on equity for shareholders.
The Motley Fool August 24, 2010 David Meier	Could Amgen Be a Multibagger? Strong returns on equity can generate powerful shareholder returns.
The Motley Fool August 25, 2010 David Meier	Could Medtronic Be a Multibagger? With higher margins than ZOLL Medical and Boston Scientific, Medtronic clearly outshines the competition.
The Motley Fool August 24, 2010 David Meier	Can Express Scripts Produce Big Returns? Express Scripts generates incredible returns on equity. Let's see how they do it.
The Motley Fool August 18, 2010 David Meier	Here's How Apple Creates Its Advantage Use the DuPont formula to identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Sysco Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Target Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How The Home Depot Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Amazon.com Creates Its Advantage Identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Wal-Mart Creates Its Advantage Wal-Mart has used its consumer advantage to generate attractive returns on equity.
The Motley Fool January 19, 2011 Jim Royal	How Do These Oil Companies Really Boost Their Returns? Let's see what the DuPont formula can tell us about Petrobras and a few of its sector and industry peers
The Motley Fool January 19, 2011 Jim Royal	How Do These Transports Really Boost Their Returns? UPS and FedEx are well-known rivals, but their returns on equity differ sharply.
The Motley Fool January 18, 2011 Jim Royal	How Do These Oil Companies Really Make Their Money? Break down Exxon-Mobil's and some of its peers' return on investment using the Dupont formula.
The Motley Fool November 30, 2010 Jim Royal	How Do These Consumer Goods Companies Really Make Their Money? Let's take a look at Procter & Gamble and a few of its sector and industry peers using the Dupont Formula.
The Motley Fool November 30, 2010 Jim Royal	How Do These Software Companies Really Make Their Money? Break it down using the Dupont formula.
The Motley Fool January 18, 2011 Jim Royal	How Does Big Pharma Really Make Its Money? As investors, we need to understand how our companies truly make their money. Thankfully, there's a neat trick developed for just that purpose: the DuPont Formula.
The Motley Fool November 12, 2011 Jim Royal	How Does Staples Boost Its Returns? As investors, we need to understand how our companies truly make their money. A neat trick developed for just that purpose - the DuPont Formula - can help us do so.
The Motley Fool December 30, 2010 Jim Royal	How Do These Beverage Companies Really Make Their Money? Let's use the Dupont formula to get a better grasp on exactly where Coca-Cola and other beverage companies are producing profit and where they might have a competitive advantage.
The Motley Fool January 19, 2011 Jim Royal	How Do These Miners Really Boost Their Returns? Let's take a look at BHP Billiton and a few of its sector and industry peers using the DuPont Formula, to see how they actually make their money.
The Motley Fool January 18, 2011 Jim Royal	How Do These Biotechs Really Make Their Money? Break it down using the Dupont formula.
The Motley Fool August 18, 2011 Shubh Datta	What You Need to Know About Advance Auto Parts' Return on Equity Delving a little deeper into what is driving Advance's Return on Equity.
The Motley Fool August 10, 2010 Matt Koppenheffer	How'd Frontier Communications Get So Profitable? How did Frontier Communications manage to boost its return on equity?
The Motley Fool January 18, 2011 Jim Royal	How Does Big Tobacco Really Make Its Money? Breaking down a company's return on equity can often give you some insight into how it's competing against peers and what type of strategy it's using to juice its return on equity.
The Motley Fool December 30, 2010 Jim Royal	How Do These Telecoms Really Make Their Money? Breaking these telecom companies' returns on equity can give you some insight into how they're competing against peers: AT&T... Vodafone... Verizon... America Movil...
The Motley Fool January 18, 2011 Jim Royal	How Do These High-Yielding REITs Really Make Their Money? Let's take a look at Annaly Capital Management and a few of its sector and industry peers using the DuPont formula to see how they really make their money.
The Motley Fool December 29, 2010 Jim Royal	How Do These Retailers Really Make Their Money? By using the DuPont Formula, you can get a better grasp on exactly where your company is producing its profit and where it might have a competitive advantage. Let's look at Wal-Mart using this criteria.
The Motley Fool October 18, 2010 Gerard Torres	Every Investor Should Know This Stock Tool Use DuPont analysis to breakdown the profitability of stocks.
IndustryWeek August 1, 2005 Traci Purdum	IW 50 Best U.S. Manufacturers -- Methodology The formula factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
IndustryWeek June 1, 2007 Traci Purdum	IW 50 Best U.S. Manufacturers -- 2007 Methodology The formula to identify the top performing manufacturers factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
IndustryWeek June 1, 2008 Jonathan Katz	IW 50 Best U.S. Manufacturers -- 2008 Methodology The formula to determine the 50 best U.S. manufacturers factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
IndustryWeek June 1, 2006 Traci Purdum	IW 50 Best U.S. Manufacturers -- Methodology To determine the 50 best manufacturers, a formula factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
The Motley Fool December 8, 2009 Stephen Mauzy	There's More Than One Way to Turn a Buck Many investor focus on margins when asset turnover can generate sufficient profits.
The Motley Fool May 29, 2011 Andrew Tonner	Does Watson Pharmaceuticals Deserve a Spot in Your Portfolio? Although Watson Pharmaceuticals doesn't look like a stock for your portfolio right now, the search doesn't end here.
IndustryWeek June 23, 2010	IW 50 Best U.S. Manufacturers -- 2010 Methodology The formula to find the top 50 U.S. manufacturers factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
The Motley Fool August 24, 2011 Andrew Tonner	Does Bristol-Myers Squibb Look Like a Winning Investment? Bristol-Myers, Pfizer, and J&J all look tempting, trading in the mid-teens relative to their earnings.
Investment Advisor October 2009 Savita Iyer-Ahrestani	About the Manager A short biography of Charles "Chuck" Akre, founder of ACM Capital Management.
The Motley Fool July 31, 2006 Stephen D. Simpson	More Plavix Headaches for Bristol-Myers Problems with a Plavix settlement put a large chunk of earnings at risk. Investors, take note.
The Motley Fool November 17, 2009 Brian Orelli	Up 80%, It's Time to Sell Bristol-Myers to Mead Johnson: It's time to walk on your own. Investors will have an option of exchanging some or all of their Bristol-Myers shares for shares in Mead Johnson for a slight discount
The Motley Fool May 12, 2004 Rex Moore	The Beauty of ROE It's a simple measure of management effectiveness. Return on equity, or ROE, helps us determine how well management creates value for shareholders.
The Motley Fool May 1, 2007 Brian Lawler	Bristol-Myers Stops Spinning in Place Bristol-Myers releases first-quarter financial results. Investors, take note.
The Motley Fool September 17, 2008 Brian Orelli	IPO? In This Market? Bristol-Myers continues with plans to spin off its nutritionals business.
The Motley Fool February 17, 2005 Nathan Parmelee	Should You Still Hold Starbucks? What are the company's growth prospects? In Starbucks' case the ROE is quite less than the P/E and the growth rate, but it is improving, and an ROE of 17% with almost no leverage is very good.
The Motley Fool October 20, 2010 Seth Jayson	Where Is Bristol-Myers Squibb's Bottom Line Headed? Here's the current margin snapshot for Bristol-Myers Squibb and some of its sector and industry peers and direct competitors.
The Motley Fool September 11, 2008 Brian Lawler	ImClone and Bristol-Myers' Unfinished Business ImClone rejects Bristol's offer, but likely isn't done dealing with it yet.
The Motley Fool June 28, 2004 Jeff Hwang	Watson Pharmaceuticals Tumbles The generic drug business at Watson Pharmaceuticals is still going strong; it's the branded products that are causing trouble.
The Motley Fool June 30, 2010 Brian Orelli	Is Bristol-Myers Squibb a Buy? Bristol-Myers is a better buy than Eli Lilly for one major reason: its resources.